Scientists are developing a new type of immunotherapy for cancer treatment called Tri-specific killer engagers (TriKEs). TriKEs are designed to activate natural killer (NK) cells, which are a type...
A new study has shown promising results for the use of fourth-generation CAR-T cell therapy in the treatment of breast cancer. CAR-T cell therapy involves genetically modifying a patient’s...
Researchers have developed a new approach to stimulate T cell responses against breast cancer cells. The researchers identified neoantigens, which are unique markers found on cancer cells, from patient-derived...
Scientists have developed a new type of CAR T cell therapy that could be more effective in treating multiple myeloma, a type of blood cancer. This new therapy uses...
Scientists have developed a new immunotherapy approach for cholangiocarcinoma (CCA), a type of cancer that originates in the bile ducts. The researchers identified neoantigens, which are unique markers found...
Image by Belova59/pixabay The reversibility of butyrophilin-like1 (Btnl1)-deficience in mice suggested cancer cells thrive in the absence of Vγ7+ cells, which play the pivotal role of human and mouse...
Image by fernandozhiminaicela/pixabay Nucleolin (NCL) has a functional role in cancer regulation. Targeting surface NCL impaired the progression of several cancer cell types in vitro and in vivo. The...
Image by AhmadArdity/pixabay Carcinoma-associated fibroblasts (CAFs) secrete IL-6-induced doxorubicin (Dox) resistance and PD-L1 expression through STAT3 and AKT pathways, play a critical role in breast cancer progression and reduce...
Image by bdyczewski/pixabay S100 calcium-binding protein A2 (S100A2) which has been proposed as a potential marker in many types of cancer, however, the prognostic value of S100A2 in colorectal...
Photo by Karolina Grabowska/pexels Cholangiocarcinoma (CCA), a highly aggressive and deadly cancer, poses significant challenges in terms of effective treatment options and patient survival rates. In the quest for...